Which SLR Platform to Choose: The Short Answer Selecting the right AI-powered systematic literature review (SLR) platform in 2027 requires teams to prioritize validated screening accuracy, recall and precision, complete source-level traceability, configurable human oversight at every decision point, and native support for living reviews. Platforms that meet these standards help HEOR, medical affairs, and…

EU JCA Dossier Submission Requirements and Deadlines: An Overview Selecting the right JCA dossier preparation platform determines whether health technology developers can meet the 100-day (or 60-day accelerated) submission window under Regulation (EU) 2021/2282 while producing complete, transparent, and audit-ready clinical evidence. The European Union Joint Clinical Assessment (JCA) requires developers to submit a structured…

AI-Powered JCA Readiness: An Overview AI-Powered JCA readiness has moved from theoretical discussion to measurable practice. Validation against the first three published EU Joint Clinical Assessment reports shows that structured AI workflows can deliver a complete, source-traceable anticipated scope (comparators, outcomes, and PICO sets) in under one hour when given only population and intervention as…

Dossier Preparation With AI: What Changes and What Does Not Dossier preparation with AI changes three things: who drafts the first version, how reviewers verify each claim, and what happens when a source document updates. The structure of an AMCP dossier, a global value dossier (GVD), or an HTA submission stays the same. The expertise…

HTACG AI Principles in JCA The HTACG AI Principles in JCA are three rules- accountability, transparency and reporting, that the EU HTA Coordination Group adopted on 15 July 2026 for any use of AI in preparing a Joint Clinical Assessment dossier. MadeAi supports them with a human approval gate at every workflow stage, a timestamped…

What Does JCA Scoping to Evidence Synthesis Mean for Dossier Readiness? JCA scoping to evidence synthesis is the chain of work that turns an anticipated EU Joint Clinical Assessment (JCA) scope into a submission-ready evidence base. End-to-end capability means one PI(E)COS (Population, Intervention/Exposure, Comparison, Outcome, Study Design) data model carries scope anticipation, protocol, search, screening,…